ezetimibe is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals (usa) Inc.. The primary component is Ezetimibe.
| Product ID | 68382-773_4834ca55-a236-42db-9097-b63d503d05c7 | 
| NDC | 68382-773 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | ezetimibe | 
| Generic Name | Ezetimibe | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2017-08-09 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA204331 | 
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. | 
| Substance Name | EZETIMIBE | 
| Active Ingredient Strength | 10 mg/1 | 
| Pharm Classes | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2017-08-09 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA204331 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-08-09 | 
| Marketing Category | ANDA | 
| Application Number | ANDA204331 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-08-09 | 
| Marketing Category | ANDA | 
| Application Number | ANDA204331 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2017-08-09 | 
| Marketing Category | ANDA | 
| Application Number | ANDA204331 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-08-09 | 
| Marketing Category | ANDA | 
| Application Number | ANDA204331 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2017-08-09 | 
| Marketing Category | ANDA | 
| Application Number | ANDA204331 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-08-09 | 
| Marketing Category | ANDA | 
| Application Number | ANDA204331 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2017-08-09 | 
| Ingredient | Strength | 
|---|---|
| EZETIMIBE | 10 mg/1 | 
| SPL SET ID: | f852b12f-e25f-415b-b1e2-58955d609507 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0591-3713 | Ezetimibe | Ezetimibe | 
| 0615-8300 | Ezetimibe | Ezetimibe | 
| 0781-5690 | Ezetimibe | Ezetimibe | 
| 0904-6664 | Ezetimibe | Ezetimibe | 
| 0904-7103 | Ezetimibe | Ezetimibe | 
| 16714-813 | Ezetimibe | Ezetimibe | 
| 16729-433 | EZETIMIBE | EZETIMIBE | 
| 31722-628 | EZETIMIBE | EZETIMIBE | 
| 42291-314 | Ezetimibe | Ezetimibe | 
| 49884-228 | Ezetimibe | Ezetimibe | 
| 50090-2717 | Ezetimibe | Ezetimibe | 
| 50090-3087 | Ezetimibe | Ezetimibe | 
| 50090-3402 | Ezetimibe | Ezetimibe | 
| 50090-3422 | Ezetimibe | Ezetimibe | 
| 50090-3657 | Ezetimibe | Ezetimibe | 
| 50228-379 | Ezetimibe | Ezetimibe | 
| 50268-298 | Ezetimibe | Ezetimibe | 
| 51660-200 | Ezetimibe | Ezetimibe | 
| 59651-052 | Ezetimibe | Ezetimibe | 
| 60429-982 | Ezetimibe | Ezetimibe | 
| 60505-2945 | Ezetimibe | Ezetimibe | 
| 60687-284 | Ezetimibe | Ezetimibe | 
| 60687-373 | Ezetimibe | Ezetimibe | 
| 67877-490 | Ezetimibe | Ezetimibe | 
| 68382-773 | ezetimibe | ezetimibe | 
| 68462-226 | Ezetimibe | Ezetimibe | 
| 69238-1154 | Ezetimibe | Ezetimibe | 
| 70518-1783 | Ezetimibe | Ezetimibe | 
| 70518-1927 | Ezetimibe | Ezetimibe | 
| 70771-1109 | ezetimibe | ezetimibe | 
| 71205-145 | Ezetimibe | Ezetimibe | 
| 71335-0933 | Ezetimibe | Ezetimibe | 
| 63629-7413 | Ezetimibe | Ezetimibe | 
| 71205-277 | Ezetimibe | Ezetimibe | 
| 71335-1127 | Ezetimibe | Ezetimibe | 
| 70518-2262 | Ezetimibe | Ezetimibe | 
| 71335-1354 | Ezetimibe | Ezetimibe | 
| 21695-778 | Zetia | Ezetimibe | 
| 50090-0833 | Zetia | Ezetimibe | 
| 55154-5031 | Zetia | Ezetimibe | 
| 55154-5034 | Zetia | Ezetimibe | 
| 55154-5043 | Zetia | Ezetimibe |